Demecan announced the successful completion of its latest funding round, marking a significant step forward in its growth strategy. This influx of capital will enhance pharmacy distribution capabilities through innovative SaaS solutions and the company's online pharmacy platform www.herbery.de. Furthermore, investments will be made into internationalization and product innovation.
Jörg Sellmann, Managing Director and responsible for finance, adds: "This financing round is a significant milestone for Demecan. It gives us the necessary resources to accelerate our growth trajectory and capitalize on the burgeoning opportunities within the medical cannabis sector, especially following its reclassification in April. Demecan has the best basis for this, as positive results have already been achieved since April and will improve further due to the full utilization of production capacities in accordance with the new cannabis law in Germany."
The round, led by Florida-based Trog Hawley Capital, with additional participation from new and existing investors, represents the first institutional investment from a U.S. based investor in Demecan. Trog Hawley Capital provides capital and strategic advice to exceptional entrepreneurs and management teams, leveraging over 10 years of experience building and investing in U.S. multi-state cannabis operators. The participation of international investors with such experience underscores Demecan's strength as the market leader, as well as the potential of the German market for medical cannabis.
"We are pleased with the support of our investors, and their trust in our good work," says Dr. Constantin von der Groeben, co-founder and Managing Director of Demecan. "The participation of new investors from the USA shows that our approach and vision are recognized internationally."
Adam Ryan, CEO of Trog Hawley, adds: "Europe's cannabis market, particularly Germany, presents exceptional growth prospects far exceeding those in more mature markets. Demecan's comprehensive infrastructure, including its production facilities and Cannabis Campus with advanced laboratory and processing capabilities, positions it as a frontrunner in the industry. We are very excited to be part of the team and look forward to supporting their next growth phase."
For more information:
Demecan
[email protected]
www.demecan.de
Sign up for our daily Newsletter and stay up to date with all the latest news!
Subscribe I am already a subscriber